Heterogeneity in age-related white matter changes

Reinhold Schmidt1, Helena Schmidt, Johannes Haybaeck

  • 1Division of Special Neurology, Department of Neurology, Medical University of Graz, Austria. reinhold.schmidt@medunigraz.at

Acta Neuropathologica
|June 28, 2011
PubMed

Insights

White matter changes in elderly brains are diverse. Some lesions are non-vascular, while others indicate ischemic damage and progress rapidly, highlighting potential therapeutic targets.

Area of Science:

  • Neurology
  • Radiology
  • Genetics

Background:

  • White matter changes are common in elderly individuals' brain MRI scans.
  • These changes exhibit heterogeneous MRI appearances and histopathological correlates.
  • Distinguishing between non-vascular and ischemic white matter lesions is crucial for understanding their progression.

Purpose of the Study:

  • To investigate the heterogeneous nature of white matter changes in the aging brain.
  • To differentiate between vascular and non-vascular origins of white matter lesions.
  • To explore genetic and molecular pathways implicated in white matter lesion development and progression.

Main Methods:

  • Analysis of MRI findings and histopathological correlates of white matter changes.
  • Classification of white matter lesions based on morphology and location (periventricular vs. subcortical/deep).
  • Application of microarray, genome-wide association studies (GWAS), and advanced MRI techniques (diffusion tensor imaging, magnetization transfer imaging).

Main Results:

  • Smooth periventricular hyperintensities are likely non-vascular, linked to ependymal lining disruption.
  • Punctate white matter lesions may represent widened perivascular spaces, while confluent lesions indicate ischemic damage and progress rapidly.
  • GWAS identified a significant locus on chromosome 17q25 associated with white matter lesion load; apolipoprotein E (ApoE) immunoreactivity was observed in lesions.

Conclusions:

  • White matter changes in the elderly are complex, with distinct origins and progression patterns.
  • Understanding the genetic and molecular underpinnings, including immune function and ApoE, is key for potential therapeutic interventions.
  • Advanced imaging techniques and further pre- and postmortem studies are needed to fully characterize these changes.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...